Policy Statements

Policy Statements

ASTCT regularly issues policy statements on a wide range of topics regarding bone marrow transplantation and cellular therapy.

When is stem cell transplantation indicated? ASTCT's executive committee approves sponsors evidence-based reviews of scientific and medical literature to answer that question and improve patient care. These reviews are guided by a panel of transplant specialists, disease-specific experts, third-party payers and patient advocates and serve to:

  • Help doctors and patients make treatment decisions
  • Provide support for broader and more consistent coverage from insurance companies
  • Identify areas where more research is needed
  • ASTCT's executive committee-approved statements also provide expert guidance on topics such as medical tourism and the collection and preservation of cord blood for personal use.

Cellular Therapy

Clinical Practice

General

Operations

Coding and Reimbursement


See also:

ASTCT Submits Letter to CMS on Options for CAR-T Inpatient Payment for FY 2021 - November 2019
ASTCT Submits Letter to CMS on National Coverage Decision for CAR-T Cell Therapy for Cancers – August 2019
ASTCT Submits Letter on FY2020 IPPS Proposed Rule – June 2019
ASTCT Submits Comments on the CMS NCA for CAR-T – March 2019
ASTCT and ASH Submit Letter on CMS Medicare Inpatient Final Rule – November 2018
ASTCT Urges Senate to Revise ACHA - Ensure Access to Care - May 2017
ASTCT Statements on American Health Care Act and Proposed NIH Budget Cuts - released March 2017
ASTCT Official Statement Opposing Executive Order on Immigration - released January 2017


Advocacy Resources:

Request for New MS-DRGs for CAR-T Therapy for FY 2019 (November 2017)
Request for CMS to Invoke CMMI Authority for CAR-T Drug Reimbursement for Medicare and Medicaid Patients (November 2017)
ASTCT Problem Statement Summary Letter on Expected CAR-T Reimbursement Concerns (September 2017)
FY2018 IPPS Proposed Rule Comment Letter, CAR-T NTAP commentary pp. 11-20 (June 2017)
ASTCT Comment Letter regarding CMS issuance of code Q2041 (February 9, 2018)
CMS CAR-T NCA Announcement (May 16, 2018)
Comments from Centers for Medicare & Medicaid Services; HCPCS Committee Meeting (May 16, 2018)
ASTCT/CIBMTR/NMDP Comment on NCA for CAR-T (June 13, 2018)
CAR-T NCA and CMS IPPS Town Hall Presentation (June 14, 2018)
ASTCT Letter to CMS IPPS Proposed Rule (June 22, 2018)